In the lockdown, while I was on regular OPD and ICU rounds at a COVID hospital, I started noticing some mild symptoms of the Coronavirus infection. Being in the medical field and considering the severity of the pandemic situation then, I was very careful and cautious, and observed the symptoms closely. The symptoms persisted and I had to self-quarantine until the medical test reports came. It was important for me to isolate myself from the rest of the medical team and prevent the spread of the virus. Finally, the report came: I was COVID positive! Stunned and slightly devastated; I broke the news to my family who could not believe it either. As a doctor, I could only treat, comfort and empathize with the COVID patients undergoing treatment; completely isolated from their loved ones. But now, I could actually feel the uncertainty of the situation. I was hospitalized and continued to experience body-ache during the admission. It was a stressful situation where I felt anxious and stressed about everything. My CT scan reports showed mild lung infection on the day of admission but as the cytokines storm developed, my lungs were 76 % damaged in 3-5 days and I was short of breath and my oxygen level deteriorated to less than 80.  I was shifted to an ICU with high-flow oxygen and was on a BiPap machine which I had purchased a few weeks ago for the hospital and never imagined that I would be using myself one day.

Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

K. Hariram reports on the OPPI 50th Annual General Meeting held in Mumbai on October 21. The report also features photos from the conference. Other topics covered include the role of emotions in pharma marketing, the importance in preparing much before-hand for the next level of your pharma career and the concept of the "tipping point" and its relevance for pharma marketing.

Measurement and optimization for digital marketing is one of...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...

Here is an analytical blog comparing the IQVIA MFR...

The latest PharmaTrac report for December 2025 offers a...

Zydus’ ZYCUBO May Be the Proof Point the Industry...

For more than fifty years, the MRI industry treated...

The Telangana Drugs Control Administration’s stop-use notice on a...